Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

Aruna V Krishnan1, Donna M Peehl, David Feldman

  • 1Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA.

Insights

Vitamin D (1,25(OH)(2)D(3)) inhibits prostate cancer (PCa) cell growth by arresting the cell cycle. Clinical trials show it can slow prostate-specific antigen rise, indicating therapeutic potential for PCa.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Prostate cancer (PCa) cells express vitamin D receptors (VDR).
  • 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) inhibits the growth of normal, benign, and cancerous prostate epithelial cells.
  • Enzymes 25-hydroxyvitamin D(3) 24-hydroxylase and 25-hydroxyvitamin D(3) 1alpha-hydroxylase modulate 1,25(OH)(2)D(3) activity.

Purpose of the Study:

  • To investigate the antiproliferative effects of 1,25(OH)(2)D(3) in prostate cancer cells.
  • To identify target genes regulated by 1,25(OH)(2)D(3) in prostate cancer.
  • To explore the therapeutic potential of 1,25(OH)(2)D(3) in prostate cancer patients.

Main Methods:

  • Cell culture experiments with LNCaP human PCa cells.
  • cDNA microarray analyses of prostatic epithelial and PCa cells.
  • A small clinical trial in PCa patients measuring prostate-specific antigen (PSA) levels.

Main Results:

  • 1,25(OH)(2)D(3) induces cell cycle arrest in PCa cells, primarily through IGFBP-3 and p21.
  • Microarray analysis revealed numerous 1,25(OH)(2)D(3)-regulated genes involved in growth, oxidative stress, and cell interactions.
  • A clinical trial demonstrated that 1,25(OH)(2)D(3) can slow the rate of PSA rise in PCa patients.

Conclusions:

  • 1,25(OH)(2)D(3) exhibits antiproliferative activity in prostate cancer via cell cycle arrest and regulation of multiple target genes.
  • These findings support the therapeutic potential of calcitriol and its analogs for prostate cancer treatment and chemoprevention.
  • Further research is warranted to fully elucidate the role of vitamin D in managing prostate cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...